During the treatment of 4T1 tumors, the C108 group had slower tumor growth, resulting in significantly smaller tumors compared with control and anti‐PD‐L1, indicating that C108 is a potent inhibitor of tumor growth. This evidence concerns the gene CD274 and neoplasm.